Inaugural dissertation on Yellow Fever and on the treatment of that disease by saline medicines

Previous to my graduation in Edinburgh on the 1st of August 1845, I submitted to the Faculty of Medicine a Thesis on Yellow Fever. This Thesis I have since corrected and enlarged, and now venture to publish. The labour of writing it was not great, for the materials furnished to me by my father were abundant. The original copies of his manuscripts are deposited in the Army Medical Board Office in London, and may be seen by any member of the profession. The plan of my Thesis is taken in part from a manuscript copy of the Lectures on Medicine delivered by the late Dr. John Gregory in the University of Edinburgh in 1770-1771. the Appendix contains a report by my father on the Principles to be observed in providing Barracks and Hospitals for Troops in the West Indies, dated Barbados 1844; and many of these principles have since been adopted by the government

Ursinus College Alumni Journal, November 1968

Ursinus College calendar • Politics 1968: That was the year that was • From the President • All-Ursinus anniversary drive: A report from the National Chairman • Stained glass on campus • An end of Pax Americana • Freeland Hall: A birthplace revisited • Episodes in the life of Freeland Hall • Homecoming 1968 • Centennial: The liberal arts in higher learning • Sports scene: Miss Snell honored; Harriers keep winning; Mills keeps kicking • Ursinus honors four at Founders\u27 Day • Church appeal gains momentum • Class of \u2772: A pictorial essay • Campus clippings: Alumni award planned; Television stars; Beatle buff on campus; Subscribe to the Weekly • Class notes • Weddings • Births • In memoriamhttps://digitalcommons.ursinus.edu/alumnijournal/1093/thumbnail.jp

Ursinus College Alumni Journal, March 1964

Standing room only • New student facilities building • Campaign receipts reach $285,765 at mid-March • Matching gifts • Mid-year report of 1964 Loyalty Fund campaign • Income while you live . . . benefaction when you die • Cutting campus • John Fitzgerald Kennedy • Eccentricities of our political life • A bitter dramatic example • Crisis of conscience in Dallas • Student reaction to November 22-25 • Two recipients for 1964 alumni award • The class of 1911 • The alumni album: C. Richard Snyder, \u2729; William D. Reimert, \u2724; Wainright E. H. Diehl, \u2751; Marguerite Goldthwaite Godshall, \u2732; Franklin E. Morris, \u2741; J. William Ditter, Jr., \u2743; Robert Poole, III, \u2750; Bain and Edwards\u27 sons: football foes • Nominees for alumni association offices • Class notes • Weddings • Births • Necrology • Regionalshttps://digitalcommons.ursinus.edu/alumnijournal/1079/thumbnail.jp

Prevention and Mitigation of Acute Radiation Syndrome in Mice by Synthetic Lipopeptide Agonists of Toll-Like Receptor 2 (TLR2)

Bacterial lipoproteins (BLP) induce innate immune responses in mammals by activating heterodimeric receptor complexes containing Toll-like receptor 2 (TLR2). TLR2 signaling results in nuclear factor-kappaB (NF-κB)-dependent upregulation of anti-apoptotic factors, anti-oxidants and cytokines, all of which have been implicated in radiation protection. Here we demonstrate that synthetic lipopeptides (sLP) that mimic the structure of naturally occurring mycoplasmal BLP significantly increase mouse survival following lethal total body irradiation (TBI) when administered between 48 hours before and 24 hours after irradiation. The TBI dose ranges against which sLP are effective indicate that sLP primarily impact the hematopoietic (HP) component of acute radiation syndrome. Indeed, sLP treatment accelerated recovery of bone marrow (BM) and spleen cellularity and ameliorated thrombocytopenia of irradiated mice. sLP did not improve survival of irradiated TLR2-knockout mice, confirming that sLP-mediated radioprotection requires TLR2. However, sLP was radioprotective in chimeric mice containing TLR2-null BM on a wild type background, indicating that radioprotection of the HP system by sLP is, at least in part, indirect and initiated in non-BM cells. sLP injection resulted in strong transient induction of multiple cytokines with known roles in hematopoiesis, including granulocyte colony-stimulating factor (G-CSF), keratinocyte chemoattractant (KC) and interleukin-6 (IL-6). sLP-induced cytokines, particularly G-CSF, are likely mediators of the radioprotective/mitigative activity of sLP. This study illustrates the strong potential of LP-based TLR2 agonists for anti-radiation prophylaxis and therapy in defense and medical scenarios

Post-mortem volatiles of vertebrate tissue

Volatile emission during vertebrate decay is a complex process that is understood incompletely. It depends on many factors. The main factor is the metabolism of the microbial species present inside and on the vertebrate. In this review, we combine the results from studies on volatile organic compounds (VOCs) detected during this decay process and those on the biochemical formation of VOCs in order to improve our understanding of the decay process. Micro-organisms are the main producers of VOCs, which are by- or end-products of microbial metabolism. Many microbes are already present inside and on a vertebrate, and these can initiate microbial decay. In addition, micro-organisms from the environment colonize the cadaver. The composition of microbial communities is complex, and communities of different species interact with each other in succession. In comparison to the complexity of the decay process, the resulting volatile pattern does show some consistency. Therefore, the possibility of an existence of a time-dependent core volatile pattern, which could be used for applications in areas such as forensics or food science, is discussed. Possible microbial interactions that might alter the process of decay are highlighted

COVID-19 trajectories among 57 million adults in England: a cohort study using electronic health records

BACKGROUND: Updatable estimates of COVID-19 onset, progression, and trajectories underpin pandemic mitigation efforts. To identify and characterise disease trajectories, we aimed to define and validate ten COVID-19 phenotypes from nationwide linked electronic health records (EHR) using an extensible framework. METHODS: In this cohort study, we used eight linked National Health Service (NHS) datasets for people in England alive on Jan 23, 2020. Data on COVID-19 testing, vaccination, primary and secondary care records, and death registrations were collected until Nov 30, 2021. We defined ten COVID-19 phenotypes reflecting clinically relevant stages of disease severity and encompassing five categories: positive SARS-CoV-2 test, primary care diagnosis, hospital admission, ventilation modality (four phenotypes), and death (three phenotypes). We constructed patient trajectories illustrating transition frequency and duration between phenotypes. Analyses were stratified by pandemic waves and vaccination status. FINDINGS: Among 57 032 174 individuals included in the cohort, 13 990 423 COVID-19 events were identified in 7 244 925 individuals, equating to an infection rate of 12·7% during the study period. Of 7 244 925 individuals, 460 737 (6·4%) were admitted to hospital and 158 020 (2·2%) died. Of 460 737 individuals who were admitted to hospital, 48 847 (10·6%) were admitted to the intensive care unit (ICU), 69 090 (15·0%) received non-invasive ventilation, and 25 928 (5·6%) received invasive ventilation. Among 384 135 patients who were admitted to hospital but did not require ventilation, mortality was higher in wave 1 (23 485 [30·4%] of 77 202 patients) than wave 2 (44 220 [23·1%] of 191 528 patients), but remained unchanged for patients admitted to the ICU. Mortality was highest among patients who received ventilatory support outside of the ICU in wave 1 (2569 [50·7%] of 5063 patients). 15 486 (9·8%) of 158 020 COVID-19-related deaths occurred within 28 days of the first COVID-19 event without a COVID-19 diagnoses on the death certificate. 10 884 (6·9%) of 158 020 deaths were identified exclusively from mortality data with no previous COVID-19 phenotype recorded. We observed longer patient trajectories in wave 2 than wave 1. INTERPRETATION: Our analyses illustrate the wide spectrum of disease trajectories as shown by differences in incidence, survival, and clinical pathways. We have provided a modular analytical framework that can be used to monitor the impact of the pandemic and generate evidence of clinical and policy relevance using multiple EHR sources. FUNDING: British Heart Foundation Data Science Centre, led by Health Data Research UK

Current concept of abdominal sepsis : WSES position paper

Peer reviewe

2013 WSES guidelines for management of intra-abdominal infections

Peer reviewe